Technical Analysis for ENOB - Enochian Biosciences, Inc.

Grade Last Price % Change Price Change
F 3.07 -1.29% -0.04
ENOB closed down 1.29 percent on Monday, April 19, 2021, on 49 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Flat
Historical ENOB trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Wide Bands Range Expansion -1.29%
Oversold Stochastic Weakness -1.29%
Stochastic Buy Signal Bullish -4.36%
Wide Bands Range Expansion -4.36%
Up 3 Days in a Row Strength -4.36%
Oversold Stochastic Weakness -4.36%
Shooting Star Candlestick Bearish 0.99%
Wide Bands Range Expansion 0.99%
Oversold Stochastic Weakness 0.99%
Older End-of-Day Signals for ENOB ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
10 DMA Support about 16 hours ago
Down 3% about 16 hours ago
Down 2 % about 16 hours ago
60 Minute Opening Range Breakdown about 19 hours ago
Down 1% about 19 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Enochian Biosciences, Inc. Description

Enochian Biosciences Inc., a pre-clinical stage biotechnology company, focuses on development of human therapeutics for infectious diseases and cancers. The company's lead candidate include ENOB-HV-01 for autologous HIV curative treatment. Its pipeline development products consist of ENOB-HV-11, a preventive HIV vaccine; and ENOB-HV-12, a therapeutic HIV vaccine. The company's pipeline development products also include ENOB-DB-01, a therapeutic cancer vaccine for the long term maintenance and prevention of relapse for the treatment of stage III and IV colon cancer patients; ENOB-DC-11 Innovative DC vaccine for multiple solid tumors; and ENOB-DC-21 for intratumoral injection. The company has strategic partnerships with The Scripps Institute and Fred Hutchinson Cancer Center. Enochian BioSciences was incorporated in 2017 and is based in Los Angeles, California.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Solid Tumors Infectious Diseases Cancers Vaccine Vaccination HIV Cancer Center Cancer Vaccine Scripps Hiv Vaccine

Is ENOB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 13.43
52 Week Low 2.6
Average Volume 308,599
200-Day Moving Average 3.56
50-Day Moving Average 3.69
20-Day Moving Average 3.34
10-Day Moving Average 3.06
Average True Range 0.30
ADX 15.64
+DI 17.81
-DI 20.16
Chandelier Exit (Long, 3 ATRs ) 3.76
Chandelier Exit (Short, 3 ATRs ) 3.75
Upper Bollinger Band 4.00
Lower Bollinger Band 2.67
Percent B (%b) 0.3
BandWidth 40.02
MACD Line -0.19
MACD Signal Line -0.18
MACD Histogram -0.0085
Fundamentals Value
Market Cap 143.18 Million
Num Shares 46.6 Million
EPS -0.48
Price-to-Earnings (P/E) Ratio -6.40
Price-to-Sales 0.00
Price-to-Book 0.82
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.43
Resistance 3 (R3) 3.45 3.34 3.37
Resistance 2 (R2) 3.34 3.25 3.34 3.35
Resistance 1 (R1) 3.21 3.20 3.16 3.19 3.33
Pivot Point 3.10 3.10 3.08 3.10 3.10
Support 1 (S1) 2.97 3.01 2.92 2.95 2.81
Support 2 (S2) 2.86 2.96 2.86 2.79
Support 3 (S3) 2.73 2.86 2.77
Support 4 (S4) 2.71